← All guides Guide · For residents and visitors

USVI Cannabis Testing: What Gets Checked Before It Reaches You

Every legal cannabis product sold in the USVI has to pass independent lab testing first. Here is what labs screen for, what the limits are, and how to read a Certificate of Analysis.

Updated August 21, 2026

In this guide8 sections

Before any legal cannabis product reaches a shelf in the US Virgin Islands, an independent laboratory has to sign off on it. That lab checks two things: that the label is honest about how strong the product is, and that the product is free of the contaminants that make cannabis unsafe.

The rules live in the Virgin Islands Cannabis Testing Standards, the policy the Office of Cannabis Regulation put into effect on May 14, 2026. This guide walks through what that testing actually covers, in plain terms.

Who has to test, and when

Testing applies to everyone in the supply chain: cultivators, manufacturers, dispensaries, and the laboratories themselves. Any cannabis product meant for inhalation, ingestion, topical use, or other human use has to be tested before it transfers to a dispensary or releases to a consumer.

The lab doing that testing has to be independent. It must hold ISO/IEC 17025 accreditation, use validated methods, take part in proficiency programs, and keep chain-of-custody records. It cannot own a stake in the cultivation, manufacturing, or dispensary business whose product it is testing, and it cannot alter results, issue false Certificates of Analysis, or take money to change an outcome.

Until a batch has passing results in hand, it stays on hold. It cannot be sold, transferred, or released from quarantine.

The Core Testing Panel

Every product, whatever its form, runs through a mandatory Core Testing Panel. On top of that, each product type gets its own additional tests.

Potency

The lab reports cannabinoid content so the label can be trusted. At minimum it measures ten cannabinoids:

Delta-9 THC, delta-8 THC, THCA, THCV, CBD, CBDA, CBG, CBGA, CBN, and CBC.

Label potency has to be accurate within a 10 percent variance, reported in milligrams per gram, or milligrams per unit for edibles. Two shorthand formulas do the heavy lifting on a label:

  • Total THC = delta-9 THC + (THCA x 0.877)
  • Total CBD = CBD + (CBDA x 0.877)

Contaminant screening

The safety half of the Core Testing Panel is a set of hard limits. A result over any of these is a failed test.

Heavy metals. Strict limits, in parts per million:

MetalLimit
Arsenic0.2 ppm
Cadmium0.2 ppm
Lead0.5 ppm
Mercury0.1 ppm

Microbials. Certain pathogens have to be absent entirely, tested at not detected in 1 gram: E. coli, Salmonella, and four Aspergillus molds (fumigatus, flavus, niger, and terreus). Yeast, mold, and general bacteria counts have their own numeric caps, set lower for extracts and inhalables than for raw flower.

Mycotoxins. Total aflatoxins and ochratoxin A each capped at 20 parts per billion. Required for all inhalable products, raw plant material, and anything meant to be eaten.

Pesticides. Only pesticides on the approved list may be used, each with its own residue limit. The panel screens a minimum of 60 analytes, and any pesticide that is not on the approved list has to come back not detected.

Foreign material. Products have to be visibly free of mold, mildew, hair, insects, metal, plastic, packaging debris, and fecal matter.

What each product type adds

The Core Testing Panel is the floor. What sits on top of it depends on the product.

  • Flower, pre-roll, kief. Adds water activity and moisture testing. Flower has to come in at or below 0.65 water activity, with moisture between 5 and 13 percent, and a lab target of 8 to 12 percent. Flower over 0.65 water activity is a failed result.
  • Extracts, concentrates, inhalables. Adds residual solvent testing. Benzene is capped at 1 part per million, with published limits for methanol, butane, propane, hexane, toluene, and others, and any unapproved solvent has to be not detected. Inhalable products also may not contain certain additives at all: vitamin E acetate, polyethylene glycol, MCT oil, synthetic terpenes, benzoic acid, or diketones such as diacetyl. Added terpenes cannot exceed 10 percent by weight.
  • Edibles. Adds homogeneity testing, so the dose is spread evenly through the batch: no more than 15 percent relative standard deviation and no more than 15 percent potency variance.
  • Topicals and tinctures. Core Testing Panel, plus microbial testing for water-based products and residual solvent testing for anything made by extraction.

Reading a Certificate of Analysis

The Certificate of Analysis is the receipt for all of this. Under the standards, every COA has to carry the lab’s name and license number, the sample and testing dates, the batch identification, the methods used, the analytes tested with their results and units, and a clear pass or fail against each action limit, signed by an authorized analyst.

The part that matters most to a shopper: COAs have to be accessible to consumers by QR code. When dispensaries open, a package should let you scan through to the lab results rather than take the label’s word for it.

When a batch fails

A batch fails if any contaminant exceeds its action limit, if any prohibited substance or unapproved pesticide or solvent turns up, or if the lab finds an unidentified contaminant it judges a risk to health. A result that merely reaches 75 percent of an action limit already triggers mandatory reporting to OCR.

A failed batch is quarantined immediately and cannot be sold or transferred. From there:

  • It may be remediated only where OCR permits, and only with full documentation, a retest, and a clean pass on every panel before release.
  • Products contaminated with a prohibited substance can be ordered destroyed and may not be remediated.
  • Labs and licensees may not conceal, dilute, relabel, or blend a failed batch to bury the result.

Why this matters for the timeline

The testing standards are one of the pieces the whole retail launch waits on. No product can be sold until it passes testing, and testing needs an accredited laboratory operating in the territory. A testing lab has been under construction on St. Croix since spring 2026, and standing it up is part of why regulated sales have not started. The Cannabis Advisory Board approved the lab testing standards that OCR then published as policy.

What to watch

  • The first accredited USVI testing laboratory clearing the last step and coming online. It gates the first legal retail sale.
  • Whether OCR tightens any action limit further for inhalable products, which the standards allow it to do.
  • QR-code COA access showing up on real packaging once dispensaries open, which is the consumer-facing proof the system works.

Frequently asked

Is cannabis sold in the USVI lab tested?
It has to be. Under the Virgin Islands Cannabis Testing Standards, every cannabis product intended for inhalation, ingestion, or topical use must pass testing at an independent ISO/IEC 17025 accredited laboratory before it can move to a dispensary or reach a consumer.
What does cannabis testing check for?
Two things. First, potency: how much THC, CBD, and other cannabinoids the product actually contains, so the label is accurate within 10 percent. Second, safety: pesticides, heavy metals, mold and bacteria, mycotoxins, residual solvents, and foreign material, each against a published limit.
What is a Certificate of Analysis?
A Certificate of Analysis, or COA, is the lab document that reports a product's test results. In the USVI, COAs have to be accessible to consumers by QR code, so you can scan a package and see what the lab found.
Can a failed batch still be sold?
No. A batch that fails is quarantined and cannot be sold or transferred. It may be remediated and retested only where OCR allows it, and products contaminated with a prohibited substance are destroyed, not fixed.